What Infervision does

Infervision is a Beijing-headquartered AI medical imaging company founded in 2015/2016 that develops deep learning and computer vision software to assist in disease screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. Its portfolio is organized into four software families: InferRead (diagnostic detection covering lung nodules, stroke, pneumonia, coronary stenosis, and bone fractures), InferOperate (3D reconstruction for thoracic, liver, and urology surgical planning, including a unified FDA-cleared Suite), InferCare (longitudinal patient management including the RECIST tumor response platform), and InferScholar/InferMatrix (research and application platforms), plus InferAir, a 25 kg ultra-portable X-ray device for offline TB screening. The company monetizes through B2B enterprise licensing of its AI software to hospitals and imaging centers on a quote-based demo sales motion, with no publicly disclosed pricing, and supplements direct sales with channel partnerships through Microsoft (Precision Imaging Network / Nuance), NVIDIA (MONAI framework and TensorRT inference), SimonMed in the US, and UN agencies (UNDP, Global Fund, UNOPS) for government health programs. Infervision holds regulatory clearances across all five major markets — FDA, CE, UKCA, PMDA, and NMPA (including multiple Class III NMPA registrations) — operates offices in China, Germany, the UK, and the US, and reports active deployment across 30+ countries with 380+ filed patents and 330+ peer-reviewed publications.

Name

Infervision

Legal name

Infervision

Website

https://global.infervision.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Infervision is a Beijing-based AI medical imaging company that develops deep learning software for disease screening, diagnosis, surgical planning, and oncology management, serving hospitals, imaging centers, and government health programs across 30+ countries with regulatory clearances in the US, Europe, UK, Japan, and China.

Ownership category

akta.pro rank

Product category

AI Medical Imaging Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Software Publishers (513210), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)

Keywords

• AI medical imaging
• Diagnostic imaging software
• Surgical planning software
• Oncology AI
• Tuberculosis screening

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. AI Medical Imaging Software Licenses: Infervision generates revenue through licensing its AI medical imaging software products including InferRead (diagnosis), InferOperate (surgical planning), InferCare (patient management), and InferScholar (research platform). The company operates across multiple regulatory markets (FDA, CE, UKCA, PMDA, NMPA) enabling global software deployment. Revenue is primarily B2B, sold to hospitals and healthcare institutions.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Infervision develops and sells AI-powered medical imaging software that applies deep learning and computer vision to support screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. The portfolio spans lung and chest screening, stroke triage, coronary analysis, bone age assessment, pneumonia detection, and a dedicated line of surgical planning and post-treatment follow-up tools sold primarily to hospitals, radiology departments, and public health programs.

Product overview

Infervision is an AI medical technology company offering a comprehensive portfolio of medical imaging AI solutions organized into three main product lines: InferRead (disease screening and diagnosis), InferOperate (surgical planning), and InferCare/InferScholar (patient management and research). InferRead products provide AI-powered analysis across multiple imaging modalities including CT scans and X-rays, covering lung cancer screening, stroke detection, bone fractures, pneumonia, and coronary artery assessment. InferOperate Suite delivers automated 3D reconstruction for preoperative surgical planning across thoracic, liver, and urology procedures. The ecosystem is supported by InferCare for patient management and longitudinal tracking, InferScholar for research applications, and InferMatrix for AI model deployment. InferAir extends the portfolio with an ultra-portable X-ray device for remote TB screening.

Differentiator

Problem solved

Functional benefit

Brands

• InferRead: AI-assisted disease screening and diagnosis product line including CT Lung, DR Chest, CT Coronary, CT Stroke, CT Bone, and CT Pneumonia solutions
• InferOperate
• InferCare
• InferScholar
• InferMatrix
• InferAir

Products and services

• InferRead CT Lung AI-powered lung CT analysis solution for lung cancer screening and pulmonary nodule detection, designed for hospitals, radiology departments, and large-scale lung cancer screening programs.
• InferRead DR Chest AI-assisted digital chest X-ray interpretation software that detects and classifies thoracic abnormalities, including tuberculosis, targeting hospitals, TB screening programs, and government public-health initiatives.
• InferRead CT Stroke AI triage software that analyzes non-contrast head CT scans to flag suspected intracerebral hemorrhage and large vessel occlusion, supporting emergency radiology and stroke centers in time-critical decisions.
• InferRead CT Coronary AI software for coronary CT angiography that performs automatic coronary artery segmentation, plaque characterization, and stenosis assessment, intended for cardiology departments and advanced imaging centers.
• InferRead CT Bone AI bone analysis software that automates bone age assessment and supports orthopedic CT interpretation for hospitals, pediatric imaging, and orthopedic departments.
• InferRead CT Pneumonia AI software that detects, segments, and quantifies pneumonia-related opacities on chest CT, designed to support radiology departments during high-volume infectious disease surges such as COVID-19.
• InferOperate Thorax Planning AI surgical planning software that performs automatic lung lesion segmentation and 3D anatomical reconstruction to support thoracic surgeons in pre-operative planning.
• InferOperate Liver Planning AI software for liver surgical planning that provides automatic liver and lesion segmentation, vascular reconstruction, and volumetric analysis for hepatobiliary surgeons.
• InferOperate Urology Planning AI surgical planning software that performs automatic kidney and prostate segmentation with 3D reconstruction, supporting urologists in pre-operative planning.
• InferOperate Suite Unified surgical planning platform that consolidates InferOperate thoracic, liver, and urology planning modules into a single clinical workflow environment for surgical departments.
• InferCare AI-enabled patient management software that organizes imaging findings, longitudinal records, and follow-up workflows for oncology and chronic disease management in hospital settings.
• InferCare RECIST FDA-cleared AI software that performs automated tumor response assessment according to RECIST 1.1 criteria, supporting oncologists and radiology teams in follow-up imaging workflows.
• InferScholar Medical imaging AI research platform that enables hospitals and research institutions to develop, validate, and operationalize custom deep learning models for clinical research projects.
• InferMatrix Integrated AI application platform that hosts and orchestrates multiple Infervision imaging AI modules within a unified clinical workflow interface for hospitals and imaging centers.
• InferAir Portable digital X-ray device with embedded AI for chest and tuberculosis screening, designed for mobile clinics, remote health programs, and resource-limited healthcare settings.

Quantifiable outcome

• 93.1% station-specific sensitivity for detecting cancerous lymph nodes in chest CT scans
• +6 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature13 records

Partnerships

Twelve partnerships are on record, tiered core, major, strategic and minor.

• MicrosoftcoreTechnology or Integration · 30 November 2025InferVision's AI models have been integrated into the Microsoft Precision Imaging Network (Microsoft + Nuance). Through cloud deployment via Azure, this partnership enables accelerated, standardized, and widely accessible intelligent imaging workflows for healthcare institutions worldwide. The integration leverages Microsoft's healthcare customer base and cloud infrastructure.
• NVIDIAcoreTechnology or Integration · 30 November 2025InferVision leverages NVIDIA's advanced MONAI framework and TensorRT-accelerated inference to enhance AI development across screening, diagnosis, surgical planning, and oncology analysis. The MONAI framework has improved InferVision's R&D efficiency, while NVIDIA's DLI training supports advancement of large-model technologies.
• Sanford HealthmajorStrategic or Co-development PartnerResearch collaboration with Sanford Health (largest rural nonprofit healthcare system in the US with 56 hospitals and nearly 300 clinics) for AI-powered cancer detection. Sanford Health researchers used Infervision's AI system combining RetinaNet detection algorithm with UNet segmentation model for detecting cancerous lymph nodes in chest CT scans, achieving 93.1% station-specific sensitivity.
• SimonMedmajorStrategic or Co-development PartnerPartnership with SimonMed, one of the largest outpatient medical imaging providers in the US. Established in 2023, this partnership enables Infervision to access a large network of imaging centers for deployment of AI diagnostic solutions.
• United Nations Development Programme (UNDP)majorChannel Partner/ Reseller/ DistributorPartnership with UNDP for TB screening programs in developing countries. UNDP and governments work together to deploy Infervision's AI solutions for tuberculosis screening in countries like Kyrgyzstan and Zimbabwe.
• Global FundmajorChannel Partner/ Reseller/ DistributorPartnership with Global Fund for deployment of AI-powered TB screening in resource-limited settings. The Global Fund supports health programs in developing countries and has partnered with Infervision to deploy InferAir technology.
• Harvard UniversitystrategicStrategic or Co-development PartnerMedical mission partnership with Harvard University for deploying InferAir (AI-powered ultra-portable X-ray) in remote Philippines islands. Harvard researchers collaborated with Partners in Health and Infervision for healthcare delivery to underserved populations.
• Partners in HealthstrategicStrategic or Co-development PartnerPartnership with Partners in Health for medical missions deploying AI-powered healthcare solutions in remote areas. Combined effort with Harvard University and Infervision for remote island healthcare delivery.
• University Hospital FrankfurtminorStrategic or Co-development PartnerClinical collaboration with University Hospital Frankfurt where Dr. Sayzana Kassahun uses InferOperate Thorax for thoracic surgery planning. The hospital serves as a reference site and provides clinical feedback for product development.
• Hôpital Tenon (Tenon University Hospital Paris)minorStrategic or Co-development PartnerClinical collaboration with Hôpital Tenon in Paris where Dr. Harry Etienne uses InferOperate Thorax for minimally invasive thoracic surgery. The hospital serves as a reference site for surgical planning AI.
• NHS (UK National Health Service)majorChannel Partner/ Reseller/ DistributorInfervision product selected into NHS procurement list in 2022, enabling deployment across UK National Health Service hospitals and healthcare facilities.
• European Commission / UNOPSmajorChannel Partner/ Reseller/ DistributorProduct procured by the European Commission and included in medical devices ordering list under Global Drug Facility (GDF) hosted by United Nations Office for Project Services (UNOPS) in 2020. Enables deployment in European and international health programs.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• DeepHealth (RadNet): DeepHealth, a RadNet subsidiary, provides AI-powered diagnostic and screening radiology solutions including lung, breast, and prostate imaging. It competes with Infervision's InferRead product line and benefits from RadNet's large outpatient imaging footprint, similar to Infervision's SimonMed partnership.
• Qure.ai: Qure.ai develops deep learning algorithms for chest X-ray, CT lung nodule detection, head CT triage, and tuberculosis screening — closely matching Infervision's product portfolio. It is a direct competitor in both hospital radiology and government TB screening programs in emerging markets.
• Lunit: Lunit is a Korea-based medical AI company with FDA-cleared chest X-ray and mammography AI products (Lunit INSIGHT). It competes with InferRead DR Chest and similar lung cancer screening use cases and has overlapping hospital and screening program customers.
• Viz.ai: Viz.ai specializes in AI-powered stroke and cardiology triage, with FDA-cleared algorithms for large vessel occlusion detection and care coordination. It directly overlaps with Infervision's InferRead CT Stroke and CT Coronary products and competes for similar hospital radiology and neurovascular contracts.
• Aidoc: Aidoc is a leading AI medical imaging company offering deep learning algorithms for triage and detection across CT and X-ray modalities (e.g., stroke, pulmonary embolism, intracranial hemorrhage). It competes directly with Infervision's InferRead suite in hospital AI workflows and shares similar enterprise sales motion and regulatory clearance strategy.
• Annalise.ai: Annalise.ai provides comprehensive AI analysis across chest X-ray and CT, including 130+ findings detection. It competes directly with InferRead DR Chest and CT Lung in multi-finding chest imaging workflows and targets similar hospital radiology customers.

Emerging players

• Nanox (Zebra Medical Vision): Nanox acquired Zebra Medical Vision, an AI medical imaging company with broad population-health imaging algorithms across CT and X-ray. It overlaps with Infervision's screening and diagnosis portfolio and competes in value-based care AI deployment models.

Broad incumbents

• Philips (IntelliSpace AI): Philips is a global medical imaging incumbent with IntelliSpace AI, an imaging informatics platform offering Algorithm Marketplace integration with third-party AI including radiology AI. As a broad incumbent, it competes with Infervision by offering embedded AI within its installed PACS/imaging base.
• Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion, a radiology AI suite integrated into its imaging modalities and teamplay platform. As a major imaging equipment OEM, it competes with Infervision's InferRead and InferOperate by bundling AI into installed scanner bases.

Regional players

• United Imaging Intelligence: United Imaging Intelligence is the AI subsidiary of United Imaging Healthcare, a major Chinese medical imaging equipment manufacturer. It offers AI-powered imaging analytics for CT, MR, and X-ray, serving similar hospital customers in China and competing with Infervision's domestic Chinese business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/inferVISION

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds6 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infervision